Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 456

1.

Statins are associated with a reduced risk of Alzheimer disease regardless of lipophilicity. The Rotterdam Study.

Haag MD, Hofman A, Koudstaal PJ, Stricker BH, Breteler MM.

J Neurol Neurosurg Psychiatry. 2009 Jan;80(1):13-7. doi: 10.1136/jnnp.2008.150433. Epub 2008 Oct 17.

PMID:
18931004
[PubMed - indexed for MEDLINE]
2.

Statin use and the risk of incident dementia: the Cardiovascular Health Study.

Rea TD, Breitner JC, Psaty BM, Fitzpatrick AL, Lopez OL, Newman AB, Hazzard WR, Zandi PP, Burke GL, Lyketsos CG, Bernick C, Kuller LH.

Arch Neurol. 2005 Jul;62(7):1047-51.

PMID:
16009757
[PubMed - indexed for MEDLINE]
3.

Do statins reduce risk of incident dementia and Alzheimer disease? The Cache County Study.

Zandi PP, Sparks DL, Khachaturian AS, Tschanz J, Norton M, Steinberg M, Welsh-Bohmer KA, Breitner JC; Cache County Study investigators.

Arch Gen Psychiatry. 2005 Feb;62(2):217-24.

PMID:
15699299
[PubMed - indexed for MEDLINE]
4.

Serum lipids, lipid-lowering drugs, and the risk of breast cancer.

Eliassen AH, Colditz GA, Rosner B, Willett WC, Hankinson SE.

Arch Intern Med. 2005 Oct 24;165(19):2264-71.

PMID:
16246993
[PubMed - indexed for MEDLINE]
5.

Statin drugs and risk of advanced prostate cancer.

Platz EA, Leitzmann MF, Visvanathan K, Rimm EB, Stampfer MJ, Willett WC, Giovannucci E.

J Natl Cancer Inst. 2006 Dec 20;98(24):1819-25.

PMID:
17179483
[PubMed - indexed for MEDLINE]
Free Article
6.

Statin therapy and risk of dementia in the elderly: a community-based prospective cohort study.

Li G, Higdon R, Kukull WA, Peskind E, Van Valen Moore K, Tsuang D, van Belle G, McCormick W, Bowen JD, Teri L, Schellenberg GD, Larson EB.

Neurology. 2004 Nov 9;63(9):1624-8.

PMID:
15534246
[PubMed - indexed for MEDLINE]
7.

APOE genotype, cholesterol level, lipid-lowering treatment, and dementia: the Three-City Study.

Dufouil C, Richard F, Fiévet N, Dartigues JF, Ritchie K, Tzourio C, Amouyel P, Alpérovitch A.

Neurology. 2005 May 10;64(9):1531-8.

PMID:
15883313
[PubMed - indexed for MEDLINE]
8.

Serum cholesterol and risk of Alzheimer disease: a community-based cohort study.

Li G, Shofer JB, Kukull WA, Peskind ER, Tsuang DW, Breitner JC, McCormick W, Bowen JD, Teri L, Schellenberg GD, Larson EB.

Neurology. 2005 Oct 11;65(7):1045-50.

PMID:
16217057
[PubMed - indexed for MEDLINE]
9.

Reduced risk of incident AD with elective statin use in a clinical trial cohort.

Sparks DL, Kryscio RJ, Sabbagh MN, Connor DJ, Sparks LM, Liebsack C.

Curr Alzheimer Res. 2008 Aug;5(4):416-21.

PMID:
18690839
[PubMed - indexed for MEDLINE]
10.

Drug costs associated with non-adherence to cholesterol management guidelines for primary prevention of cardiovascular disease in an elderly population: the Rotterdam study.

Gumbs PD, Verschuren WM, Mantel-Teeuwisse AK, de Wit AG, Hofman A, Trienekens PH, Stricker BH, de Boer A, Klungel OH.

Drugs Aging. 2006;23(9):733-41.

PMID:
17020397
[PubMed - indexed for MEDLINE]
11.

HMG-CoA reductase inhibitors and the risk of vertebral fracture.

Schoofs MW, Sturkenboom MC, van der Klift M, Hofman A, Pols HA, Stricker BH.

J Bone Miner Res. 2004 Sep;19(9):1525-30. Epub 2004 Jun 21.

PMID:
15312254
[PubMed - indexed for MEDLINE]
12.

Cancer risk among statin users: a population-based cohort study.

Friis S, Poulsen AH, Johnsen SP, McLaughlin JK, Fryzek JP, Dalton SO, Sørensen HT, Olsen JH.

Int J Cancer. 2005 Apr 20;114(4):643-7.

PMID:
15578694
[PubMed - indexed for MEDLINE]
13.

Statin but not non-statin lipid-lowering drugs decrease fracture risk: a nation-wide case-control study.

Rejnmark L, Vestergaard P, Mosekilde L.

Calcif Tissue Int. 2006 Jul;79(1):27-36. Epub 2006 Jul 24.

PMID:
16868664
[PubMed - indexed for MEDLINE]
14.

Adherence to and dosing of beta-hydroxy-beta-methylglutaryl coenzyme A reductase inhibitors in the general population differs according to apolipoprotein E-genotypes.

Maitland-van der Zee AH, Stricker BH, Klungel OH, Mantel-Teeuwisse AK, Kastelein JJ, Hofman A, Leufkens HG, van Duijn CM, de Boer A.

Pharmacogenetics. 2003 Apr;13(4):219-23.

PMID:
12668918
[PubMed - indexed for MEDLINE]
15.

Association of dyslipidemia and effects of statins on nonmacrovascular diseases.

Baghdasarian SB, Jneid H, Hoogwerf BJ.

Clin Ther. 2004 Mar;26(3):337-51. Review.

PMID:
15110128
[PubMed - indexed for MEDLINE]
16.

Prior statin therapy is associated with a decreased rate of severe sepsis.

Almog Y, Shefer A, Novack V, Maimon N, Barski L, Eizinger M, Friger M, Zeller L, Danon A.

Circulation. 2004 Aug 17;110(7):880-5. Epub 2004 Aug 2.

PMID:
15289367
[PubMed - indexed for MEDLINE]
Free Article
17.

Amyotrophic lateral sclerosis-like conditions in possible association with cholesterol-lowering drugs: an analysis of patient reports to the University of California, San Diego (UCSD) Statin Effects Study.

Golomb BA, Kwon EK, Koperski S, Evans MA.

Drug Saf. 2009;32(8):649-61. doi: 10.2165/00002018-200932080-00004.

PMID:
19591530
[PubMed - indexed for MEDLINE]
18.

Statin use and breast cancer: prospective results from the Women's Health Initiative.

Cauley JA, McTiernan A, Rodabough RJ, LaCroix A, Bauer DC, Margolis KL, Paskett ED, Vitolins MZ, Furberg CD, Chlebowski RT; Women's Health Initiative Research Group.

J Natl Cancer Inst. 2006 May 17;98(10):700-7.

PMID:
16705124
[PubMed - indexed for MEDLINE]
Free Article
19.

Statins and cancer risk.

Karp I, Behlouli H, Lelorier J, Pilote L.

Am J Med. 2008 Apr;121(4):302-9. doi: 10.1016/j.amjmed.2007.12.011.

PMID:
18374689
[PubMed - indexed for MEDLINE]
20.

Use of statins and fracture: results of 4 prospective studies and cumulative meta-analysis of observational studies and controlled trials.

Bauer DC, Mundy GR, Jamal SA, Black DM, Cauley JA, Ensrud KE, van der Klift M, Pols HA.

Arch Intern Med. 2004 Jan 26;164(2):146-52.

PMID:
14744837
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk